In 2024, GoodRx reported that 19 drug approvals had a significant clinical impact.
These medications and vaccines, deemed "influential" by the FDA, were approved this year.
2024 brought some major advancements in medicine.
This year, the FDA approved innovative drugs such as Tryvio for high blood pressure, Neffy for severe allergic reactions, and Dupixent for chronic obstructive pulmonary disease (COPD).
According to GoodRx, a California-based digital health care platform, these medications are expected to have a significant clinical impact on those who require them.
In 2024, GoodRx published a list of the 19 most significant drug and vaccine approvals, which included both new treatments for specific conditions and additional uses for existing medications.
Here is the list in order of FDA approval date.
Eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus) is an additional use for Dupixent.
2. Amtagvi – New medication: Advanced melanoma
3. Xolair – Additional use: Food allergies
4. Wegovy – Additional use: Cardiovascular risk reduction
5. Tryvio – New medication: High blood pressure
6. Nexletol – Additional use: High cholesterol
7. Winrevair – New medication: Pulmonary arterial hypertension
8. mRESVIA – New vaccine: RSV
9. Capvaxive – New vaccine: Pneumococcal disease
10. Wakix – Additional use: Pediatric narcolepsy
11. Ohtuvayre – New medication: COPD
12. Kisunla – New medication: Alzheimer's disease
Heartburn from non-erosive GERD (gastroesophageal reflux disease) can be managed with additional use of Voquezna.
14. Zunveyl – New medication: Alzheimer's disease
15. Hypoparathyroidism (low levels of the parathyroid hormone) is a new medication called Yorvipath.
For more Health articles, visit planetchronicle.net/health
16. Neffy – New medication: Severe allergic reactions
17. FluMist – Additional use: Self- or caregiver-administration
18. Cobenfy – New medication: Schizophrenia
19. Dupixent – Additional use: COPD
GoodRx created a list of first-in-class medications and vaccines that are expected to have a significant impact on human health, according to a disclaimer.
The company defined the number of lives touched or the expected degree of impact for future medication recipients as the measure of success.
"We prioritized medications with notable advantages over those recommended by clinical treatment guidelines or mainstay medical organizations based on effectiveness or safety data."
Planet Chronicle Digital reached out to GoodRx for comment.
health
You might also like
- To detect more bird flu cases, the CDC advises quicker 'subtyping'.
- The Lincoln Park Zoo in Chicago has suffered losses due to bird flu, with both a flamingo and a seal succumbing to the illness.
- New diagnoses increase for certain cancer groups, despite decline in death rates, according to report.
- The FDA has banned red food dye, while the health effects of wildfires are being studied.
- Nutritionists express disappointment over the long-awaited red food dye ban: 'It should have happened sooner'